Maintenance Notice (4:00 AM - 9:00 AM August 24, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Product Document Searching Made Easy by 2D Code! | [TCIPracticalExample] The Synthesis of α-Aminoamide Catalyzed...
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 345627-80-7 | Product Number: N1274
SNS-032
×
![]()
×
Purity: >95.0%(HPLC)(qNMR)
Synonyms:
- BMS 387032
- N-[5-[[[5-(tert-Butyl)oxazol-2-yl]methyl]thio]thiazol-2-yl]piperidine-4-carboxamide
- SNS 032
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 10MG |
₹7,000.00
|
Contact Us | ≥40 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | N1274 |
Purity / Analysis Method 
|
>95.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C__1__7H__2__4N__4O__2S__2 = 380.53 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 345627-80-7 |
| Reaxys Registry Number | 9654646 |
| MDL Number | MFCD09833875 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(qNMR) | min. 95.0 % |
| Melting point | 170.0 to 174.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 172 °C |
GHS
Related Laws:
| RTECS# | TM6071000 |
Transport Information:
Application
SNS-032: A Cyclin-Dependent Kinase (CDK) Inhibitor
Cyclins and cyclin-dependent kinases (CDKs) are a key component of the regulatory proteins that control the cell cycle. CDK plays a critical role in regulating the cell cycle transition and is primarily involved in the pathogenesis of cancer. SNS-032 (BMS 387032) is a CDK inhibitor that competes for ATP binding sites on these kinases, thereby reducing tumor growth and inducing cell death. There are reports that SNS-032 inhibits CDK2, CDK7, and CDK9 and leads to growth arrest and apoptosis of tumor cell lines. (The product is for research purpose only.)
References
- N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highlyefficacious and selective antitumor agent
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
- SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
- Discovery of BMS-387032, a potent cyclin-dependent kinase inhibitor in clinical development (a review)
- Cyclin-dependent kinase modulators and cancer therapy (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.